Care Capital Investments Iii L.p. - Net Worth and Insider Trading

Care Capital Investments Iii L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Care Capital Investments Iii L.p. owns 6 companies in total, including Agile Therapeutics Inc (AGRX) , Vaxart Inc (VXRT) , and Rocket Pharmaceuticals Inc (RCKT) among others .

Click here to see the complete history of Care Capital Investments Iii L.p.’s form 4 insider trades.

Insider Ownership Summary of Care Capital Investments Iii L.p.

Ticker	Comapny	Transaction Date	Type of Owner
AGRX	Agile Therapeutics Inc	2014-05-22	10 percent owner
VXRT	Vaxart Inc	2018-02-13	10 percent owner
RCKT	Rocket Pharmaceuticals Inc	2015-06-24	10 percent owner
		2015-05-11	10 percent owner
		2014-06-30	10 percent owner
		2014-02-14	director & 10 percent owner

Care Capital Investments Iii L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Care Capital Investments Iii L.p. Ownership Network

Ownership Network List of Care Capital Investments Iii L.p.

No Data

Ownership Network Relation of Care Capital Investments Iii L.p.

Care Capital Investments Iii L.p. Owned Company Details

What does Agile Therapeutics Inc do?

Who are the key executives at Agile Therapeutics Inc?

Care Capital Investments Iii L.p. is the 10 percent owner of Agile Therapeutics Inc. Other key executives at Agile Therapeutics Inc include Chief Financial Officer Scott M Coiante , Chief Commercial Officer Amy Welsh , and director & Chief Executive Officer Alfred Altomari .

Agile Therapeutics Inc (AGRX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Agile Therapeutics Inc (AGRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Agile Therapeutics Inc (AGRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Agile Therapeutics Inc (AGRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Agile Therapeutics Inc Insider Transactions

No Available Data

What does Vaxart Inc do?

Who are the key executives at Vaxart Inc?

Care Capital Investments Iii L.p. is the 10 percent owner of Vaxart Inc. Other key executives at Vaxart Inc include Chief Financial Officer Phillip E Lee , Interim CFO Fuad Ahmad , and SVP & General Counsel Edward B Berg .

Vaxart Inc (VXRT) Insider Trades Summary

Over the past 18 months, Care Capital Investments Iii L.p. made no insider transaction in Vaxart Inc (VXRT). Other recent insider transactions involving Vaxart Inc (VXRT) include a net purchase of 20,000 shares made by W. Mark Watson ,

In summary, during the past 3 months, insiders sold 0 shares of Vaxart Inc (VXRT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Vaxart Inc (VXRT) were sold and 20,000 shares were bought by its insiders, resulting in a net purchase of 20,000 shares.

Vaxart Inc (VXRT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vaxart Inc Insider Transactions

No Available Data

What does Rocket Pharmaceuticals Inc do?

Who are the key executives at Rocket Pharmaceuticals Inc?

Care Capital Investments Iii L.p. is the 10 percent owner of Rocket Pharmaceuticals Inc. Other key executives at Rocket Pharmaceuticals Inc include Chief Medical Officer Mark Andrew White , See Remarks John Militello , and General Counsel Martin Wilson .

Rocket Pharmaceuticals Inc (RCKT) Insider Trades Summary

Over the past 18 months, Care Capital Investments Iii L.p. made no insider transaction in Rocket Pharmaceuticals Inc (RCKT). Other recent insider transactions involving Rocket Pharmaceuticals Inc (RCKT) include a net sale of 22,492 shares made by John Militello , a net sale of 48,601 shares made by Gaurav Shah , and a net sale of 582,989 shares made by Gotham Makker .

In summary, during the past 3 months, insiders sold 19,727 shares of Rocket Pharmaceuticals Inc (RCKT) in total and bought 0 shares, with a net sale of 19,727 shares. During the past 18 months, 779,172 shares of Rocket Pharmaceuticals Inc (RCKT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 779,172 shares.

Rocket Pharmaceuticals Inc (RCKT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Rocket Pharmaceuticals Inc Insider Transactions

No Available Data

What does CoLucid Pharmaceuticals Inc do?

Who are the key executives at CoLucid Pharmaceuticals Inc?

Care Capital Investments Iii L.p. is the 10 percent owner of CoLucid Pharmaceuticals Inc. Other key executives at CoLucid Pharmaceuticals Inc include 10 percent owner Pappas Capital, Llc , 10 percent owner Lilly Eli & Co , and 10 percent owner Tvm Life Science Ventures Vii L.p. .

CoLucid Pharmaceuticals Inc (CLCD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of CoLucid Pharmaceuticals Inc (CLCD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CoLucid Pharmaceuticals Inc (CLCD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CoLucid Pharmaceuticals Inc (CLCD)'s detailed insider trading history can be found in Insider Trading Tracker table.

CoLucid Pharmaceuticals Inc Insider Transactions

No Available Data

What does Minerva Neurosciences Inc do?

Who are the key executives at Minerva Neurosciences Inc?

Care Capital Investments Iii L.p. is the 10 percent owner of Minerva Neurosciences Inc. Other key executives at Minerva Neurosciences Inc include 10 percent owner Ag Boehringer , 10 percent owner Boehringer Ingelheim International Gmbh , and EVP and Head of R&D Remy Luthringer .

Minerva Neurosciences Inc (NERV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Minerva Neurosciences Inc (NERV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Minerva Neurosciences Inc (NERV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Minerva Neurosciences Inc (NERV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Minerva Neurosciences Inc Insider Transactions

No Available Data

What does NephroGenex Inc do?

Who are the key executives at NephroGenex Inc?

Care Capital Investments Iii L.p. is the director & 10 percent owner of NephroGenex Inc. Other key executives at NephroGenex Inc include director & Chief Executive Officer Pierre Legault , director & 10 percent owner Richard J Markham , and 10 percent owner Joshua Ruch .

NephroGenex Inc (NRXGQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of NephroGenex Inc (NRXGQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NephroGenex Inc (NRXGQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NephroGenex Inc (NRXGQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

NephroGenex Inc Insider Transactions

No Available Data

Care Capital Investments Iii L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Care Capital Investments Iii L.p.. You might contact Care Capital Investments Iii L.p. via mailing address: 47 Hulfish Street, Princeton Nj 08542.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.